Oral BPC-157 Oral formulations are typically encapsulated or enteric-coated , protecting the peptide as it passes through the stomach
Ondrejickova O, Ziegelhoeffer A, Gabauer I, Sotnikova R, Styk J, Gibala P, et al
Typical: about 100 mcg CJC-1295 plus 100 mcg Ipamorelin Frequency: once or twice daily, usually before bed Best on an empty stomach Route: subcutaneous, single combined vial This content is for educational purposes only and is not a substitute for professional medical advice
Most side effects fade within 3 to 5 days
Advanced / Aggressive Protocol (2 mL = ~10.0 mg/mL) Note: The 12 mg dose represents the highest dose tested in Phase 2 trials [3] [4] , producing maximum weight-loss efficacy (~24% body weight at 48 weeks)